Raytheon E-Systems Medical Electronics (E-Med) has named RonaldFord as president and CEO of the San Antonio, TX, teleradiologycompany. Ford replaces James Karlak, who left E-Med in a restructuringin July (SCAN 7/17/96).Ford previously was director of
Raytheon E-Systems Medical Electronics (E-Med) has named RonaldFord as president and CEO of the San Antonio, TX, teleradiologycompany. Ford replaces James Karlak, who left E-Med in a restructuringin July (SCAN 7/17/96).
Ford previously was director of product assurance at the Garland,TX, division of Raytheon E-Systems, where he led the developmentand production of large-scale signal-processing systems. The Garlandunit took over R&D responsibilities for E-Med's PACSPro/DXproduct line as part of the July restructuring, leaving E-Medto concentrate on teleradiology and miniPACS components.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Key MRI Findings Predictive of Treatment Response for Unresectable Hepatocellular Carcinoma
July 14th 2025For patients with unresectable hepatocellular carcinoma, a pre-treatment MRI finding of LI-RADS tumor in vein was associated with over an 86 percent lower likelihood of responding to transcatheter arterial chemoembolization (TACE) and targeted immunotherapy.